House Bill 534

Actions | Amendments
Last Action 04/09/24: signed by Governor (Acts Ch. 155)
Title AN ACT relating to addiction treatment.
Bill Documents Acts Chapter 155
Current/Final
Introduced
Fiscal Impact Statements Actuarial Analysis
Local Mandate
Additional Fiscal Impact Statements Exist
Bill Request Number 1792
Sponsor R. Duvall
Summary of Enacted Version Amends KRS 205.536 to prohibit the Department for Medicaid Services or a Medicaid managed care organization from requiring or using certain utilization reviews for prescription drugs that contains an opioid antagonist; and amends KRS 304.17A-611 to prohibit insurers from requiring or using certain utilization reviews for prescriptions that contain an opioid antagonist, and to provide that the prohibition applies to health benefit plans issued or renewed after January 1, 2025.
Legislative History
Summary of Original Version Amend KRS 205.536 to prohibit the Department for Medicaid Services or a Medicaid managed care organization from requiring or using certain utilization reviews for prescription drugs that contain Naloxone; amend KRS 304.17A-611 to prohibit insurers from requiring or using certain utilization reviews for prescription drugs that contain Naloxone.
Index Headings of Original Version Drugs and Medicines - Treatment of alcohol or opioid use disorder, Naloxone, utilization reviews, prohibition
Insurance, Health - Treatment of alcohol or opioid use disorder, utilization review, Naloxone, prohibition
Public Medical Assistance - Medicaid coverage, utilization review, Naloxone, prohibition
State Agencies - Department for Medicaid Services, utilization review, Naloxone, prohibition
State Agencies - Department of Insurance, utilization review, Naloxone, prohibition
Medicaid - Department for Medicaid Services, utilization review, Naloxone, prohibition
Alcoholism - Treatment, Naloxone, utilization reviews, prohibition
Opioids - Treatment, Naloxone, utilization reviews, prohibition
Actuarial Analysis - Treatment, Naloxone, utilization reviews, prohibition
Local Mandate - Treatment of alcohol or opioid use disorder, utilization review, Naloxone, prohibition
Jump to Proposed Amendments House Committee Substitute 1 with Fiscal Impact Statements
Votes Vote History

Actions

Top | Amendments
02/14/24
  • introduced in House
  • to Committee on Committees (H)
02/23/24
  • to Health Services (H)
02/29/24
  • reported favorably, 1st reading, to Calendar with Committee Substitute (1)
03/01/24
  • 2nd reading, to Rules
03/05/24
  • posted for passage in the Regular Orders of the Day for Wednesday, March 06, 2024
03/06/24
  • 3rd reading, passed 94-0 with Committee Substitute (1)
03/07/24
  • received in Senate
  • to Committee on Committees (S)
03/13/24
  • to Banking & Insurance (S)
03/21/24
  • reported favorably, 1st reading, to Consent Calendar
03/22/24
  • 2nd reading, to Rules as a consent bill
03/25/24
  • posted for passage in the Consent Orders of the Day for Tuesday, March 26, 2024
03/26/24
  • passed over and retained in the Consent Orders of the Day
03/27/24
  • passed over and retained in the Consent Orders of the Day
03/28/24
  • 3rd reading, passed 37-1
  • received in House
  • enrolled, signed by Speaker of the House
  • enrolled, signed by President of the Senate
  • delivered to Governor
04/09/24
  • signed by Governor (Acts Ch. 155)

Proposed Amendments

Top | Actions
Amendment House Committee Substitute 1
Fiscal Impact Statements Actuarial Analysis to House Committee Substitute 1
Local Mandate to House Committee Substitute 1
Summary Retain original provisions, except replace "naloxone" with "an opioid antagonist"; provide Section 2 of the Act applies to health benefit plans issued or renewed after January 1, 2025; EFFECTIVE, in part, January 2025.
Index Headings Drugs and Medicines - Treatment of alcohol or opioid use disorder, opioid antagonist, utilization reviews, prohibition
Effective Dates, Delayed - Treatment, opioid antagonist, utilization reviews, prohibition, effective January 2025, in part
Insurance, Health - Treatment of alcohol or opioid use disorder, utilization review, opioid antagonist, prohibition
Public Medical Assistance - Medicaid coverage, utilization review, opioid antagonist, prohibition
State Agencies - Department for Medicaid Services, utilization review, opioid antagonist, prohibition
State Agencies - Department of Insurance, utilization review, opioid antagonist, prohibition
Medicaid - Department for Medicaid Services, utilization review, opioid antagonist, prohibition
Alcoholism - Treatment, opioid antagonist, utilization reviews, prohibition
Opioids - Treatment, opioid antagonist, utilization reviews, prohibition

Last updated: 9/26/2024 1:37 PM (EDT)